News about product and service launches
The first completely reusable 3D cell culture microplate on the market Caption: The first completely reusable 3D cell culture microplate on the market. To download image, please click here. Montreal, Canada, December 8th 2020 – Life Science Newswire – eNUVIO announced the release of the first completely reusable 3D cell culture microplate on the market. Scientific research currently consumes high-volumes of single-use... Read more
SCOTTSDALE, AZ – December 8, 2020 — SimonMed Imaging, one of the largest outpatient imaging providers in the US, is pleased to be the first in Arizona to bring a new, patient-friendly MRI technology to patients. SimonMed will deploy GE Healthcare’s SIGNA Architect 3T MRI scanner with new AIR http://www.ge.com/news/press-releases/a-better-patient-experience-at-simonmed-imaging-coming-with-new-ge-mri-tech Read more
Roche today announced that new data on its investigational T-cell engaging bispecific antibodies, mosunetuzumab, glofitamab and cevostamab, were presented at the all-virtual 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, from 5-8 December 2020, showing encouraging activity across multiple types of blood cancer. Read more
Single test for SARS-CoV-2, influenza (flu) A/B and RSV can detect and differentiate between diseases with similar clinical symptoms Read more
To keep pace with the rapid growth of the Chinese market for scientific instruments, WITec’s representative office in Beijing has moved to a larger space, now in the Air China Plaza Tower. Our new location features a dedicated equipment demonstration laboratory where visitors can experience our latest technologies in person, and see the advantages they... Read more
Basel, 07 December 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced longer-term data from the pivotal phase Ib/II GO29365 study, including data from a single-arm extension cohort of 106 additional patients, which show the benefit of Polivy® (polatuzumab vedotin) plus bendamustine and MabThera®/Rituxan® (rituximab) (BR) in people with relapsed or refractory (R/R) diffuse... Read more
Basel, 7 December 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced results from a new analysis of pooled, three-year follow-up data of 401 people with haemophilia A from the pivotal HAVEN 1-4 studies, which reinforce the long-term efficacy and safety profile of Hemlibra® (emicizumab).[1] These data, from adults, adolescents and children with haemophilia... Read more
Basel, 5 December 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from the pivotal phase III MURANO and CLL14 studies support the efficacy of fixed-duration, chemotherapy-free Venclexta®/Venclyxto® (venetoclax)-based combinations in certain people with chronic lymphocytic leukaemia (CLL) and provide more evidence on the potential value of minimal residual disease (MRD).... Read more
December 3, 2020 at 10:00 AM EST CINCINNATI, Dec. 03, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has launched an Air-Dryable RT-qPCR Mix, driving innovation in the development of molecular tests with ambient temperature stability. This specialized master mix is designed... Read more
Smart functions and tools optimize productivity and efficiency SANTA CLARA, Calif., December 02, 2020 Agilent Technologies Inc. (NYSE: A) today announced a new ICP-MS instrument, the Agilent 7850 ICP-MS System, that provides new smart tools to minimize common time traps that can affect ICP-MS analysis workflows. Building on decades of innovation, the 7850 ICP-MS combines market-leading... Read more